Polysight AI
Category: AI in Healthcare
An AI-native compliance intelligence platform designed to automate regulatory oversight and risk management for healthcare systems. Polysight AI was founded in 2024. The company is led by Rinku A. Patel. Based in Atlanta, USA. Team size: 2-10. Total funding raised: $1.0M. Latest round: Pre-seed. Key investors include Catalyst by Wellstar, Alloy Partners.
- Founded
- 2024
- Headquarters
- Atlanta, USA
- Team size
- 2-10
- Total funding
- $1.0M
Value proposition
Reduces the $39 billion annual administrative burden of healthcare compliance by transforming reactive, manual workflows into proactive, real-time intelligence.
Products and solutions
Real-time Regulatory Monitoring Engine, AI-driven Compliance Risk Scoring, Automated Policy Mapping & Gap Analysis, Compliance Intelligence Dashboard
Unique value
Unlike legacy compliance software, Polysight is built as an 'AI-native' system, utilizing large language models (LLMs) specifically tuned for the complex, high-stakes regulatory environment of US healthcare.
Target customer
Health systems, hospital networks, medical groups, and healthcare compliance officers.
Industries served
Healthcare, HealthTech, Regulatory Compliance, Data Privacy
Technology advantage
Leverages a unique 'venture studio' advantage through Catalyst by Wellstar, providing the company with direct access to clinical environments, real-world compliance data, and subject matter experts for rapid product iteration.
How they differentiate
Polysight is an 'AI-native' platform utilizing agentic large language models (LLMs) for real-time regulatory monitoring, whereas legacy competitors often rely on manual audits and reactive spreadsheets. Its primary advantage is being 'health system-born,' providing direct access to clinical workflows and real-world compliance data through its partnership with Wellstar.
Main competitors
Symplr, HealthStream, Credo
Key partnerships
Catalyst by Wellstar (Strategic Partner & Investor), Alloy Partners (Venture Studio Partner), Wellstar Health System (Initial Design & Pilot Partner)
Notable customers
Wellstar Health System
Major milestones
Launched from the Catalyst by Wellstar venture studio in January 2025, Secured $1M in pre-seed funding from strategic partners, Appointed Rinku A. Patel (former CEO of OptioRx) as CEO, Initiated a real-world pilot program with Wellstar Health System to automate regulatory oversight
Growth metrics
Currently in the pilot phase with a major U.S. health system (Wellstar).
Market positioning
Early-stage disruptor in the Healthcare Governance, Risk, and Compliance (GRC) sector.
Geographic focus
United States
Patents and IP
No registered patents disclosed as of latest update; proprietary algorithms focus on real-time regulatory data processing.
About Rinku A. Patel
Rinku A. Patel is a PharmD-trained healthcare executive with over 20 years of experience in pharmacy operations and healthcare technology. Before being selected as CEO of Polysight AI following a nationwide search, she was the CEO of OptioRx (2021-2024) and the Founder/CEO of KloudScript (2012-2021), a specialty pharmacy network that she successfully scaled and exited. She also held leadership roles at Diplomat Specialty Pharmacy as VP of Pharmacy Strategy.
Official website: https://www.polysight.ai/